glp-1 prescriptions q1 2025 Patients Face New Barriers for Drugs How Pharmacy Plans Are Managing

When GLP-1 Medications Affect Libido: Understanding the Connection and What to Do About It GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy) , tirzepatide (Mounjaro, Zepbound) , and retatrutide have transformed the management of metabolic disease

Talk to your doctor about the options before trying any new medications or supplements

Novel multi-omic biomarkers to combat oocyte and ovarian aging

GLP-1 receptor agonists, including Ozempic, Wegovy, and Zepbound, have gained widespread attention as powerful tools for weight loss and appetite regulation

Sohn, J.-W., Elmquist, J

Other reasons for Ozempic plateau include lifestyle factors that neutralize medication benefits, inconsistent injection technique affecting bioavailability, or underlying metabolic barriers unrelated to appetite hormones